In this model the C3a receptor antagonist SB290157 prevents the increase in blood pressure, proteinuria, fetal growth restriction, and increase in sFlt-1 suggesting an important role for C3a in the development of the preeclamptic symptoms and in the systemic endothelial dysfunction43. The gene discussed is C3; the disease is fetal growth restriction.